Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MITOMYCIN vs MOGAMULIZUMAB-KPKC: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

MITOMYCIN vs MOGAMULIZUMAB-KPKC: Safety Overview

Metric MITOMYCIN MOGAMULIZUMAB-KPKC
Total FAERS Reports 2,111 1,186
Deaths Reported 231 161
Death Rate 10.9% 13.6%
Hospitalizations 590 198
Average Patient Age 62.8 yrs 67.9 yrs
% Female Patients 48.8% 17.6%
FDA Approval Date Approved Prior to Jan 1, 1982 N/A
Manufacturer Accord BioPharma Inc. N/A
Route INTRAVENOUS N/A
Marketing Status Prescription Prescription